Inactivation of tumor-specific CD8+ CTLs by tumor-infiltrating tolerogenic dendritic cells-Reference-Cited by-同舟云学术

Inactivation of tumor-specific CD8+ CTLs by tumor-infiltrating tolerogenic dendritic cells

Published:2013-09-10 Issue:9 Volume:91 Page:545-555
ISSN:0818-9641
Container-title:Immunology and Cell Biology
language:en
Short-container-title:Immunol Cell Biol

Author:

Harimoto Hirotomo¹²,Shimizu Masumi¹,Nakagawa Yohko¹,Nakatsuka Katsuhisa²,Wakabayashi Ayako¹,Sakamoto Choitsu²,Takahashi Hidemi¹

Affiliation:

1. Department of Microbiology and Immunology, Nippon Medical School; Tokyo Japan

2. Third Department of Internal Medicine, Nippon Medical School; Tokyo Japan

Funder

Ministry of Education, Science, Sport, and Culture

Ministry of Health and Labor and Welfare, Japan

Japanese Health Sciences Foundation

Promotion and Mutual Aid Corporation for Private Schools of Japan

MEXT-supported Program for the Strategic Research Foundation at Private Universities, Japan

Publisher

Wiley

Subject

Cell Biology,Immunology,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1038/icb.2013.38/fullpdf

Reference33 articles.

1. Restriction of in vitro T cell-mediated cytotoxicity in lymphocytic choriomeningitis within a syngeneic or semiallogeneic system;Zinkernagel;Nature,1974

2. The infection of human dendritic cells with recombinant avipox vectors expressing a costimulatory molecule transgene (CD80) to enhance the activation of antigen-specific cytolytic T cells;Tsang;Cancer Res,2001

3. Induction of tumor-specific acquired immunity against already established tumors by selective stimulation of innate DEC-205(+) dendritic cells;Moriya;Cancer Immunol Immunother,2010

4. MHC-dependent antigen processing and peptide presentation: providing ligands for T lymphocyte activation;Germain;Cell,1994

5. Antigen processing and presentation;Takahashi;Microbiol Immunol,1993

Cited by 86 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The impact of the tumor immune microenvironment and tumor-infiltrating lymphocyte subgroups on laryngeal cancer prognosis;Science Progress;2024-07

2. Emerging therapeutic options for follicular-derived thyroid cancer in the era of immunotherapy;Frontiers in Immunology;2024-05-29

3. Nanomedicines for reversing immunosuppressive microenvironment of hepatocellular carcinoma;Biomaterials;2024-04

4. The cellular composition of the tumor microenvironment is an important marker for predicting therapeutic efficacy in breast cancer;Frontiers in Immunology;2024-02-29

5. Tumor microenvironment in thyroid cancer: Immune cells, patterns, and novel treatments;Head & Neck;2024-02-21